Results 321 to 330 of about 1,105,613 (399)

Exercise Prescription in Lung-Transplanted Cystic Fibrosis Adults. [PDF]

J Funct Morphol Kinesiol
Orlandi M, Pinnarò MS, Corsi M, Borchi B, Cavallo A, Guarducci S, Bartoloni A, Donati M, Defraia C, Nesi L, Sparacio S, Mannini C, Lavorini F, Bini V, Bresci S, Stefani L.   +15 more
europepmc   +1 more source

Real‐world outcomes of aflibercept 8 mg in patients previously treated for neovascular age‐related macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and ...
Imadeddin Abu Ishkheidem, Esra Inci, Martin Breimer, Sofia Töyrä Silfverswärd, Madeleine Zetterberg, Marita Andersson Grönlund   +5 more
wiley   +1 more source

A descriptive cohort study of pregnancy and parenthood in women with cystic fibrosis. [PDF]

Clin Med (Lond)
Duffy A, Parker S, Williams S, Hodson K, Doe S, Echevarria C, Bourke SJ.   +6 more
europepmc   +1 more source

Younger Age and Viral Triggers Were Associated With Post‐Infectious Bronchiolitis Obliterans in French Children

Acta Paediatrica, EarlyView.
ABSTRACT Aim Post‐infectious bronchiolitis obliterans (PIBO) is a rare but severe chronic paediatric obstructive lung disease, characterised by the obliteration of small airways following severe lower respiratory tract infections. Epidemiological data in Europe remain limited. Methods This multicentre retrospective study examined the characteristics of
Julie Mazenq, Marine Crebassa, Alice Hadchouel, Souad Ghattas, Philippe Reix, Laurianne Coutier, Christophe Marguet, Nadia Nathan, Lisa Giovannini‐Chami, Caroline Thumerelle, François Galode, Marie‐Catherine Renoux, Léa Roditis, Eglantine Hullo, Pierrick Cros, Laurence Weiss, Sébastien Kiefer, Marie Tochon, Brahim Allali, Katia Bessaci Kabouya, Céline Delestrain, Louisa Goumidi, Hortense Petat, Véronique Houdouin, Jean‐Christophe Dubus   +24 more
wiley   +1 more source

Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis. [PDF]

J Bras Pneumol
Silva SC, Barroso A, Cunha M, Fragoso E, Azevedo P.   +4 more
europepmc   +1 more source

Anaphylaxis Induced by Goat's and Sheep's Milk: An Allergen That We Should Keep Under Surveillance

Allergy, EarlyView.
Guillaume Pouessel, Elleni‐Sofia Vaia, Catharina Chatain, Valérie Liabeuf, Camille Braun, Anne‐Karine Correard, Elena Bradatan, Pascale Dumond, Yasemin Karaca‐Altintas, Pascale Beaumont, Delphine Delalande, Sélina Tscheiller, Xavier Van der Brempt, Carine Metz‐Favre, Amandine Divaret‐Chauveau, Dominique Sabouraud‐Leclerc   +15 more
wiley   +1 more source

Outcomes for Congenital Diaphragmatic Hernia in Three Decades: A Report From a UK Surgical Centre

Acta Paediatrica, EarlyView.
ABSTRACT Aims Congenital diaphragmatic hernia (CDH) is associated with lung hypoplasia, pulmonary hypertension and high mortality. Three decades experience from a UK centre is reported. Methods Medical records of CDH newborns between February 1990 and November 2021 and attending a multidisciplinary clinic were examined. Survival and health outcomes are
Wan Teng Lee, Paul D. Losty
wiley   +1 more source

Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation. [PDF]

Int J Neonatal Screen
McGarry ME, Raraigh KS, Farrell P, Shropshire F, Padding K, White C, Dorley MC, Hicks S, Ren CL, Tullis K, Freedenberg D, Wafford QE, Hempstead SE, Taylor MA, Faro A, Sontag MK, McColley SA.   +16 more
europepmc   +1 more source

Antimicrobial prescribing guidelines for horses in Australia

Australian Veterinary Journal, EarlyView.
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt, K Thomas, S Page, J Norris, G Browning, C El Hage, A Stewart, J Gilkerson, G Muscatello, D Verwilghen, G van Galen, J Bauquier, R Cuming, B Reynolds, C Whittaker, E Wilkes, J Clulow, C Burden, L Begg   +18 more
wiley   +1 more source